Medical News

The US Food and Drug Administration (FDA) has cleared Abbott’s FreeStyle Libre 2 integrated continuous glucose ... read more
A new analysis from an international team of investigators presented at the American Diabetes Association’s (ADA) ... read more
A new analysis of nondiabetic patients from the landmark DAPA-HF trial suggests use of dapagliflozin could ... read more
While the fields of endocrinology and cardiometabolic health have seen incredible strides in therapies and technologies ... read more
New research findings demonstrate substantial positive effects of the Affordable Care Act’s Medicaid Expansion for the ... read more
Results of the EXPERT study presented at the American Diabetes Association’s (ADA) 80th Scientific Sessions is ... read more
Initiating both basal insulin and GLP-1 receptor agonists is beneficial for patients with uncontrolled type 2 ... read more
A new analysis from investigators at the University of Florida College of Pharmacy is shedding light ... read more